title: GRAMICIDIN_U2932_12_TH001_NG_101118_07_G07

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_G07

value: GRAMICIDIN

value: 12 hrs


title: Primary tumor breast - BCPT0679

status: Public on Jul 08 2015

type: RNA

city: Stockholm

first: Alexandra

last: Jauhiainen

address: PO Box 281

department: Medical Epidemiology and Biostatistics

country: Sweden

institute: Karolinska Institutet

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status

hyb_protocol: Fragmented and biotinylated cRNA (10 μg) was hybridized at 45C for 16 h to a high density oligonucleotide custom made Affymetrix array chip (Human Cancer G110 Array). The arrays were then washed, stained with streptavidin-phycoerythrin (SAPE, final concentration of 10 μg/ml).

scan_protocol: The arrays were scanned according to the manufacturer’s instructions (Affymetrix Genechip® Technical Manual, 2001). The scanned images were inspected for the presence of obvious defects (artifacts or scratches) on the array. In case of visible microarray artifacts, the sample was rehybridized and rescanned on new chips using the same fragmented probe.

data_processing: The microarray analysis was done in the open source software R using the aroma.affymetrix package. Each array was individually background corrected and normalized using robust multichip averaging (RMA). The arrays were then quantile normalized for comparability. Only perfect match (PM) probes were used in the normalization steps. The signals from multiple PM probes targeting the same transcript were summarized using a probe level model adjusting for chip effects. A variance filter was employed and probes with inter-quartile-range less than 0.5 were excluded, resulting in 28449 retained probes.

label: biotin

molecule: total RNA

organism: Homo sapiens

source_name: Primary tumor breast

label_protocol: Preparation of in vitro transcription (IVT) products and oligonucleotide array hybridization and scanning were performed according to the Affymetrix protocol (Santa Clara, CA, USA). In brief, the amount of starting total RNA for each probe preparation varied between 2 and 5 μg. IVT reactions were performed in batches to generate biotinylated cRNA targets, which were subsequently chemically fragmented at 95C for 35 min.

extract_protocol: Extraction of total RNA from frozen tumors was carried out using the Qiagen RNeasy Mini Kit (Qiagen, Germany). The integrity of the RNA extracts was tested on an Agilent 2100 Bioanalyzer (Agilent Technologies, Rockville, MD), measuring the 28S: 18S ribosomal RNA ratio. RNA extracts of high quality were stored at -70C until microarray analyses.

treatment_protocol: The fresh frozen tumor samples were collected from liquid nitrogen and cryosectioning was performed on a Cryo-Star HM 560 M. Five μm sections were cut from the surface of the same tumor sample that was used for isolation of RNA and DNA. The section was counterstained with hematoxylin and eosin and dehydrated through graded concentrations of ethanol to xylene before mounting. The percentage of tumor cells, as well as the percentage of epithelial cancer cells in relation to stroma, was quantified in the frozen tumor sections by a breast cancer pathologist.

tag: sample group

value: validation

tag: setnr

tag: case-control status

tag: tissue

value: Primary tumor breast


title: Primary tumor breast - BCPT0842


title: TRANEXAMIC.ACID_U2932_12_TH001_NG_101118_07_G01

city: New York

first: Andrea

last: Califano

state: NY

address: 1130 St. Nicholas Avenue, Rm. 906

country: USA

institute: Columbia University

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_G01

hyb_protocol: Following fragmentation with a buffered zinc solution  (Fragmentation Reagent, Ambion), 7.5 ug of labelled cRNA were hybridized on HG-U219 arrays in 120ul volume/well. The GeneTitan Hybridization, Wash and Stain kit (Affymetrix) was used for preparing hybridization mixes and processing of 96-array plates on the GeneTitan Instrument (Affymetrix).

scan_protocol: Human Genome U219 array plate was processed in GeneTitan according to manufacturer's instructions

data_processing: The data were analyzed with RMA method in R

label_protocol: 300ng of each of the samples with RIN value >7 were converted to biotinylated cRNA with the Illumina TotalPrep-96 RNA Amplification Kit (Ambion) using a standard T7-based amplification protocol

growth_protocol: Cell lines were cultured in Iscove’s Modified Dulbecco Medium supplemented with 10% fetal bovine serum at 37°C in a 5% CO2 atmosphere.

extract_protocol: Total RNA was isolated with the RNAqueous-96 Automated Kit (Ambion) on the Janus automated liquid handling system (Perkin Elmer Inc.), quantified by NanoDrop 6000 spectrophotometer and quality checked by Agilent Bioanalyzer.

treatment_protocol: A stock concentration of the IC20 at 24 hour was created by dilution in DMSO. Cells were treated with the 24hr IC20 of each of the compounds for 6, 12, and 24hrs at 37°C, 5% CO2 under humidified conditions. 0.2% DMSO vehicle treated samples were used as controls.

tag: compound treated

tag: cell line

tag: time


title: Cladribine_U2932_12_TH001_NG_101118_07_F12

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_F12

value: Cladribine


title: CEFIXIME_U2932_12_TH001_NG_101118_07_F10

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_F10

value: CEFIXIME


title: TAMOXIFEN.CITRATE_U2932_12_TH001_NG_101118_07_G05

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_G05


title: CLEMASTINE_U2932_12_TH001_NG_101118_07_G02

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_G02

value: CLEMASTINE


title: NIZATIDINE_U2932_12_TH001_NG_101118_07_F11

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_F11

value: NIZATIDINE


title: Primary tumor breast - BCPT0991

value: discovery


title: Primary tumor breast - BCPT0189


title: Primary tumor breast - BCPT0333


title: Primary tumor breast - BCPT0067


title: AMIODARONE.HYDROCHLORIDE_U2932_12_TH001_NG_101118_07_F09

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_F09


title: Primary tumor breast - BCPT0465


title: Primary tumor breast - BCPT0242


title: PYRITHIONE.ZINC_U2932_12_TH001_NG_101118_07_F07

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_F07


title: Auranofin_U2932_12_TH001_NG_101118_07_F08

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_F08

value: Auranofin


title: Primary tumor breast - BCPT0995


title: GEMFIBROZIL_U2932_12_TH001_NG_101118_07_H03

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_H03

value: GEMFIBROZIL


title: ENOXACIN_U2932_12_TH001_NG_101118_07_F06

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_F06

value: ENOXACIN


title: Primary tumor breast - BCPT0764


title: APOMORPHINE.HYDROCHLORIDE_U2932_12_TH001_NG_101118_07_F02

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_F02


title: SULFAMERAZINE_U2932_12_TH001_NG_101118_07_F05

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_F05

value: SULFAMERAZINE


title: CHLORMEZANONE_U2932_12_TH001_NG_101118_07_E10

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_E10

value: CHLORMEZANONE


title: Primary tumor breast - BCPT0568


title: Primary tumor breast - BCPT0895


title: Primary tumor breast - BCPT0738


title: Primary tumor breast - BCPT0542


title: ETHOPROPAZINE.HYDROCHLORIDE_U2932_12_TH001_NG_101118_07_F04

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_F04


title: Primary tumor breast - BCPT0161


title: Primary tumor breast - BCPT0185


title: FOLIC.ACID_U2932_12_TH001_NG_101118_07_F01

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_F01


title: Primary tumor breast - BCPT0445

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status


title: Irinotecan.Hydrochloride_U2932_12_TH001_NG_101118_07_E11

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_E11


title: TENIPOSIDE_U2932_12_TH001_NG_101118_07_E08

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_E08

value: TENIPOSIDE


title: Docetaxel_U2932_12_TH001_NG_101118_07_E07

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_E07

value: Docetaxel


title: Primary tumor breast - BCPT0271


title: GLIPIZIDE_U2932_12_TH001_NG_101118_07_E09

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_E09

value: GLIPIZIDE


title: Primary tumor breast - BCPT0499


title: MITOXANTHRONE.HYDROCHLORIDE_U2932_24_TH001_NG_101118_08_A08

description:
tumor cell line
Therasis_Plate15_TH001_NG_20101118_08_A08

value: 24 hrs


title: Primary tumor breast - BCPT0103


title: IMATINIB_U2932_12_TH001_NG_101118_07_E12

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_E12

value: IMATINIB

value: 12 hrs


title: GALLAMINE.TRIETHIODIDE_U2932_12_TH001_NG_101118_07_F03

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_F03


title: ETOPOSIDE_U2932_12_TH001_NG_101118_07_E06

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_E06

value: ETOPOSIDE


title: Primary tumor breast - BCPT0452

value: validation

value: Primary tumor breast


title: Primary tumor breast - BCPT0097


title: NITROFURAZONE_U2932_12_TH001_NG_101118_07_E04

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_E04

value: NITROFURAZONE


title: THIOTHIXENE_U2932_12_TH001_NG_101118_07_E05

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_E05

value: THIOTHIXENE


title: DYCLONINE.HYDROCHLORIDE_U2932_12_TH001_NG_101118_07_E03

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_E03


title: ECONAZOLE.NITRATE_U2932_12_TH001_NG_101118_07_E01

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_E01


title: Primary tumor breast - BCPT0472


title: Itraconazole_U2932_12_TH001_NG_101118_07_D11

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_D11

value: Itraconazole


title: Primary tumor breast - BCPT0860

value: discovery


title: VORINOSTAT_U2932_12_TH001_NG_101118_07_D12

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_D12

value: VORINOSTAT


title: Primary tumor breast - BCPT0563


title: TRIMETHADIONE_U2932_12_TH001_NG_101118_07_D09

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_D09

value: TRIMETHADIONE


title: Primary tumor breast - BCPT0698


title: Primary tumor breast - BCPT0937


title: Primary tumor breast - BCPT0710


title: Primary tumor breast - BCPT0976


title: VINCRISTINE.SULFATE_U2932_12_TH001_NG_101118_07_D07

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_D07


title: MITOMYCIN.C_U2932_12_TH001_NG_101118_07_E02

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_E02


title: Primary tumor breast - BCPT0206

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status


title: BRINZOLAMIDE_U2932_12_TH001_NG_101118_07_D10

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_D10

value: BRINZOLAMIDE


title: Primary tumor breast - BCPT0945


title: Primary tumor breast - BCPT0336


title: SULINDAC_U2932_12_TH001_NG_101118_07_D05

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_D05

value: SULINDAC


title: TOPOTECAN.HYDROCHLORIDE_U2932_12_TH001_NG_101118_07_D08

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_D08


title: CLOZAPINE_U2932_12_TH001_NG_101118_07_D06

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_D06

value: CLOZAPINE


title: DIMERCAPROL_U2932_12_TH001_NG_101118_07_G09

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_G09

value: DIMERCAPROL


title: AZATHIOPRINE_U2932_12_TH001_NG_101118_07_D02

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_D02

value: AZATHIOPRINE


title: ISOPROPAMIDE.IODIDE_U2932_12_TH001_NG_101118_07_D04

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_D04


title: Primary tumor breast - BCPT0776


title: Primary tumor breast - BCPT0317


title: Primary tumor breast - BCPT0059


title: Primary tumor breast - BCPT0334


title: MELPHALAN_U2932_12_TH001_NG_101118_07_D01

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_D01

value: MELPHALAN


title: Primary tumor breast - BCPT0644


title: Primary tumor breast - BCPT0763


title: RIFABUTIN_U2932_12_TH001_NG_101118_07_C12

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_C12

value: RIFABUTIN


title: ACETOHEXAMIDE_U2932_12_TH001_NG_101118_07_C09

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_C09

value: ACETOHEXAMIDE

value: 12 hrs


title: DACTINOMYCIN_U2932_12_TH001_NG_101118_07_C07

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_C07

value: DACTINOMYCIN


title: Primary tumor breast - BCPT0981

value: Primary tumor breast


title: Primary tumor breast - BCPT0912


title: FULVESTRANT_U2932_12_TH001_NG_101118_07_C10

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_C10

value: FULVESTRANT


title: Primary tumor breast - BCPT0758

value: validation


title: DEFEROXAMINE.MESYLATE_U2932_12_TH001_NG_101118_07_D03

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_D03


title: Primary tumor breast - BCPT0241


title: Primary tumor breast - BCPT0357


title: DIGITOXIN_U2932_12_TH001_NG_101118_07_C08

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_C08

value: DIGITOXIN


title: TROGLITAZONE_U2932_12_TH001_NG_101118_07_C11

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_C11

value: TROGLITAZONE


title: TRIFLUOPERAZINE.HYDROCHLORIDE_U2932_12_TH001_NG_101118_07_C06

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_C06


title: Primary tumor breast - BCPT0982

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status


title: SULFACETAMIDE_U2932_12_TH001_NG_101118_07_C05

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_C05

value: SULFACETAMIDE


title: Primary tumor breast - BCPT0596


title: Primary tumor breast - BCPT0486

value: discovery


title: FLURBIPROFEN_U2932_12_TH001_NG_101118_07_C04

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_C04

value: FLURBIPROFEN


title: Primary tumor breast - BCPT0905


title: MEBENDAZOLE_U2932_12_TH001_NG_101118_07_C01

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_C01

value: MEBENDAZOLE


title: Primary tumor breast - BCPT0288


title: Primary tumor breast - BCPT0697


title: Primary tumor breast - BCPT0708


title: ACRISORCIN_U2932_12_TH001_NG_101118_07_C02

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_C02

value: ACRISORCIN


title: RISPERIDONE_U2932_12_TH001_NG_101118_07_B12

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_B12

value: RISPERIDONE


title: Mometasone.furoate_U2932_12_TH001_NG_101118_07_B11

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_B11


title: ESTRADIOL_U2932_12_TH001_NG_101118_07_C03

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_C03

value: ESTRADIOL


title: PICROPODOPHYLLIN_U2932_12_TH001_NG_101118_07_B10

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_B10

value: PICROPODOPHYLLIN


title: Primary tumor breast - BCPT0839


title: VINBLASTINE.SULFATE_U2932_12_TH001_NG_101118_07_B08

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_B08


title: Primary tumor breast - BCPT0853


title: TIOCONAZOLE_U2932_12_TH001_NG_101118_07_B09

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_B09

value: TIOCONAZOLE


title: SULFASALAZINE_U2932_12_TH001_NG_101118_07_B06

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_B06

value: SULFASALAZINE


title: MICONAZOLE.NITRATE_U2932_12_TH001_NG_101118_07_B04

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_B04

value: 12 hrs


title: ROSIGLITAZONE_U2932_12_TH001_NG_101118_07_B02

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_B02

value: ROSIGLITAZONE


title: TRIFLUPROMAZINE.HYDROCHLORIDE_U2932_12_TH001_NG_101118_07_B07

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_B07


title: Primary tumor breast - BCPT0734

value: Primary tumor breast


title: Primary tumor breast - BCPT0171


title: DMSO_U2932_12_TH001_NG_101118_07_A12

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_A12

value: DMSO


title: ERGOCALCIFEROL_U2932_12_TH001_NG_101118_07_B03

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_B03

value: ERGOCALCIFEROL


title: Primary tumor breast - BCPT0782

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status


title: THIOGUANINE_U2932_12_TH001_NG_101118_07_B05

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_B05

value: THIOGUANINE


title: TUBOCURARINE.CHLORIDE_U2932_12_TH001_NG_101118_07_A10

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_A10


title: FENOFIBRATE_U2932_12_TH001_NG_101118_07_B01

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_B01

value: FENOFIBRATE


title: Primary tumor breast - BCPT0793

value: validation


title: Metixene.hydrochloride_U2932_12_TH001_NG_101118_07_A11

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_A11


title: NISOLDIPINE_U2932_12_TH001_NG_101118_07_A09

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_A09

value: NISOLDIPINE


title: CHLOROXINE_U2932_12_TH001_NG_101118_07_A07

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_A07

value: CHLOROXINE


title: PINDOLOL_U2932_12_TH001_NG_101118_07_A06

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_A06

value: PINDOLOL


title: MITOXANTHRONE.HYDROCHLORIDE_U2932_12_TH001_NG_101118_07_A08

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_A08


title: HEXACHLOROPHENE_U2932_12_TH001_NG_101118_07_A04

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_A04

value: HEXACHLOROPHENE


title: Primary tumor breast - BCPT0866


title: SULCONAZOLE.NITRATE_U2932_12_TH001_NG_101118_07_A02

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_A02


title: Primary tumor breast - BCPT0923


title: INDAPAMIDE_U2932_6_TH001_NG_101118_06_H04

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_H04

value: INDAPAMIDE

value: 6 hrs


title: CLOMIPHENE.CITRATE_U2932_12_TH001_NG_101118_07_A03

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_A03


title: Primary tumor breast - BCPT0951


title: Primary tumor breast - BCPT0040


title: Primary tumor breast - BCPT0908

value: discovery


title: SULFINPYRAZONE_U2932_12_TH001_NG_101118_07_A05

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_A05

value: SULFINPYRAZONE


title: DMSO_U2932_6_TH001_NG_101118_06_H12

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_H12


title: TINIDAZOLE_U2932_6_TH001_NG_101118_06_H06

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_H06

value: TINIDAZOLE


title: FELODIPINE_U2932_6_TH001_NG_101118_06_H10

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_H10

value: FELODIPINE


title: REF_HeLa_NA_TH001_NG_101118_07_A01

description:
tumor cell line
Therasis_Plate14_TH001_NG_20101118_07_A01

source_name: HeLa

value: REF

value: HeLa


title: Primary tumor breast - BCPT0931

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status

value: Primary tumor breast


title: DAPSONE_U2932_6_TH001_NG_101118_06_H02

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_H02

value: DAPSONE


title: Primary tumor breast - BCPT0587


title: Primary tumor breast - BCPT0223


title: RIBAVIRIN_U2932_6_TH001_NG_101118_06_H08

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_H08

value: RIBAVIRIN


title: Primary tumor breast - BCPT0150


title: ALPROSTADIL_U2932_6_TH001_NG_101118_06_H11

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_H11

value: ALPROSTADIL


title: Primary tumor breast - BCPT0806


title: Primary tumor breast - BCPT0766


title: Primary tumor breast - BCPT0012

value: validation


title: PENTOXIFYLLINE_U2932_6_TH001_NG_101118_06_H09

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_H09

value: PENTOXIFYLLINE


title: Primary tumor breast - BCPT0999


title: GEMFIBROZIL_U2932_6_TH001_NG_101118_06_H03

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_H03

value: GEMFIBROZIL


title: DMSO_U2932_6_TH001_NG_101118_06_H01

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_H01

value: DMSO


title: Gemcitabine_U2932_6_TH001_NG_101118_06_H07

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_H07

value: Gemcitabine


title: Primary tumor breast - BCPT0684


title: Primary tumor breast - BCPT0693


title: VALPROIC.ACID_U2932_6_TH001_NG_101118_06_G12

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_G12


title: Primary tumor breast - BCPT0751


title: Primary tumor breast - BCPT0742


title: Primary tumor breast - BCPT0557


title: Primary tumor breast - BCPT0711


title: Primary tumor breast - BCPT0592


title: Primary tumor breast - BCPT0354


title: Butoconazole.nitrate_U2932_6_TH001_NG_101118_06_G10

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_G10


title: DIMERCAPROL_U2932_6_TH001_NG_101118_06_G09

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_G09

value: DIMERCAPROL


title: Toremifene_U2932_6_TH001_NG_101118_06_G11

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_G11

value: Toremifene

value: 6 hrs


title: Primary tumor breast - BCPT0477

value: discovery


title: Primary tumor breast - BCPT0955


title: Primary tumor breast - BCPT0398


title: Primary tumor breast - BCPT0113


title: Primary tumor breast - BCPT0910


title: CYTARABINE_U2932_6_TH001_NG_101118_06_G08

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_G08

value: CYTARABINE


title: HYDROCHLOROTHIAZIDE_U2932_6_TH001_NG_101118_06_G04

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_G04

value: HYDROCHLOROTHIAZIDE


title: ALTRETAMINE_U2932_6_TH001_NG_101118_06_G06

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_G06

value: ALTRETAMINE


title: CLEMASTINE_U2932_6_TH001_NG_101118_06_G02

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_G02

value: CLEMASTINE


title: INDOMETHACIN_U2932_6_TH001_NG_101118_06_G03

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_G03

value: INDOMETHACIN


title: Cladribine_U2932_6_TH001_NG_101118_06_F12

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_F12

value: Cladribine


title: NIZATIDINE_U2932_6_TH001_NG_101118_06_F11

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_F11

value: NIZATIDINE


title: TRANEXAMIC.ACID_U2932_6_TH001_NG_101118_06_G01

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_G01


title: TAMOXIFEN.CITRATE_U2932_6_TH001_NG_101118_06_G05

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_G05


title: GRAMICIDIN_U2932_6_TH001_NG_101118_06_G07

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_G07

value: GRAMICIDIN


title: CEFIXIME_U2932_6_TH001_NG_101118_06_F10

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_F10

value: CEFIXIME


title: AMIODARONE.HYDROCHLORIDE_U2932_6_TH001_NG_101118_06_F09

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_F09


title: PROMAZINE.HYDROCHLORIDE_U2932_6_TH001_NG_101118_06_H05

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_H05


title: PYRITHIONE.ZINC_U2932_6_TH001_NG_101118_06_F07

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_F07


title: Primary tumor breast - BCPT0682

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status

value: Primary tumor breast


title: GALLAMINE.TRIETHIODIDE_U2932_6_TH001_NG_101118_06_F03

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_F03


title: FOLIC.ACID_U2932_6_TH001_NG_101118_06_F01

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_F01


title: Primary tumor breast - BCPT0845


title: Auranofin_U2932_6_TH001_NG_101118_06_F08

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_F08

value: Auranofin


title: ENOXACIN_U2932_6_TH001_NG_101118_06_F06

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_F06

value: ENOXACIN


title: Docetaxel_U2932_6_TH001_NG_101118_06_E07

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_E07

value: Docetaxel


title: IMATINIB_U2932_6_TH001_NG_101118_06_E12

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_E12

value: IMATINIB


title: Primary tumor breast - BCPT0153


title: CHLORMEZANONE_U2932_6_TH001_NG_101118_06_E10

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_E10

value: CHLORMEZANONE


title: SULFAMERAZINE_U2932_6_TH001_NG_101118_06_F05

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_F05

value: SULFAMERAZINE

value: 6 hrs


title: Primary tumor breast - BCPT0690

value: discovery


title: Primary tumor breast - BCPT0243


title: APOMORPHINE.HYDROCHLORIDE_U2932_6_TH001_NG_101118_06_F02

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_F02


title: Primary tumor breast - BCPT0100


title: Irinotecan.Hydrochloride_U2932_6_TH001_NG_101118_06_E11

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_E11


title: GLIPIZIDE_U2932_6_TH001_NG_101118_06_E09

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_E09

value: GLIPIZIDE


title: Primary tumor breast - BCPT0464


title: ETHOPROPAZINE.HYDROCHLORIDE_U2932_6_TH001_NG_101118_06_F04

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_F04


title: THIOTHIXENE_U2932_6_TH001_NG_101118_06_E05

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_E05

value: THIOTHIXENE


title: NITROFURAZONE_U2932_6_TH001_NG_101118_06_E04

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_E04

value: NITROFURAZONE


title: Primary tumor breast - BCPT0021

value: validation


title: MITOMYCIN.C_U2932_6_TH001_NG_101118_06_E02

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_E02


title: ETOPOSIDE_U2932_6_TH001_NG_101118_06_E06

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_E06

value: ETOPOSIDE


title: TENIPOSIDE_U2932_6_TH001_NG_101118_06_E08

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_E08

value: TENIPOSIDE


title: DYCLONINE.HYDROCHLORIDE_U2932_6_TH001_NG_101118_06_E03

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_E03


title: Primary tumor breast - BCPT0160

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status


title: Primary tumor breast - BCPT0985


title: Primary tumor breast - BCPT0854


title: TOPOTECAN.HYDROCHLORIDE_U2932_6_TH001_NG_101118_06_D08

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_D08


title: Primary tumor breast - BCPT0604


title: Primary tumor breast - BCPT0755


title: Primary tumor breast - BCPT0401


title: Primary tumor breast - BCPT0614


title: ISOPROPAMIDE.IODIDE_U2932_6_TH001_NG_101118_06_D04

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_D04


title: Primary tumor breast - BCPT0583


title: RIFABUTIN_U2932_6_TH001_NG_101118_06_C12

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_C12

value: RIFABUTIN


title: VORINOSTAT_U2932_6_TH001_NG_101118_06_D12

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_D12

value: VORINOSTAT


title: Primary tumor breast - BCPT0193

value: Primary tumor breast


title: AZATHIOPRINE_U2932_6_TH001_NG_101118_06_D02

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_D02

value: AZATHIOPRINE


title: ECONAZOLE.NITRATE_U2932_6_TH001_NG_101118_06_E01

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_E01


title: Primary tumor breast - BCPT0106


title: Primary tumor breast - BCPT0015


title: Primary tumor breast - BCPT0439


title: Itraconazole_U2932_6_TH001_NG_101118_06_D11

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_D11

value: Itraconazole


title: VINCRISTINE.SULFATE_U2932_6_TH001_NG_101118_06_D07

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_D07


title: TRIMETHADIONE_U2932_6_TH001_NG_101118_06_D09

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_D09

value: TRIMETHADIONE


title: Primary tumor breast - BCPT0623


title: Primary tumor breast - BCPT0767


title: DEFEROXAMINE.MESYLATE_U2932_6_TH001_NG_101118_06_D03

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_D03


title: FULVESTRANT_U2932_6_TH001_NG_101118_06_C10

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_C10

value: FULVESTRANT


title: SULINDAC_U2932_6_TH001_NG_101118_06_D05

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_D05

value: SULINDAC


title: MELPHALAN_U2932_6_TH001_NG_101118_06_D01

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_D01

value: MELPHALAN


title: TROGLITAZONE_U2932_6_TH001_NG_101118_06_C11

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_C11

value: TROGLITAZONE

value: 6 hrs


title: CLOZAPINE_U2932_6_TH001_NG_101118_06_D06

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_D06

value: CLOZAPINE


title: Primary tumor breast - BCPT0457

value: discovery


title: ACETOHEXAMIDE_U2932_6_TH001_NG_101118_06_C09

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_C09

value: ACETOHEXAMIDE


title: Primary tumor breast - BCPT0381

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status


title: DIGITOXIN_U2932_6_TH001_NG_101118_06_C08

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_C08

value: DIGITOXIN


title: Primary tumor breast - BCPT0562


title: TRIFLUOPERAZINE.HYDROCHLORIDE_U2932_6_TH001_NG_101118_06_C06

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_C06


title: FLURBIPROFEN_U2932_6_TH001_NG_101118_06_C04

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_C04

value: FLURBIPROFEN


title: Primary tumor breast - BCPT0622


title: SULFACETAMIDE_U2932_6_TH001_NG_101118_06_C05

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_C05

value: SULFACETAMIDE


title: Primary tumor breast - BCPT0065

value: validation


title: Primary tumor breast - BCPT0122


title: Primary tumor breast - BCPT0688


title: ACRISORCIN_U2932_6_TH001_NG_101118_06_C02

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_C02

value: ACRISORCIN


title: DACTINOMYCIN_U2932_6_TH001_NG_101118_06_C07

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_C07

value: DACTINOMYCIN


title: ESTRADIOL_U2932_6_TH001_NG_101118_06_C03

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_C03

value: ESTRADIOL


title: RISPERIDONE_U2932_6_TH001_NG_101118_06_B12

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_B12

value: RISPERIDONE


title: MEBENDAZOLE_U2932_6_TH001_NG_101118_06_C01

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_C01

value: MEBENDAZOLE


title: Primary tumor breast - BCPT0078

value: Primary tumor breast


title: Primary tumor breast - BCPT0980


title: Primary tumor breast - BCPT0968


title: Primary tumor breast - BCPT0706


title: Primary tumor breast - BCPT0447


title: Primary tumor breast - BCPT0843


title: TIOCONAZOLE_U2932_6_TH001_NG_101118_06_B09

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_B09

value: TIOCONAZOLE


title: Mometasone.furoate_U2932_6_TH001_NG_101118_06_B11

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_B11


title: PICROPODOPHYLLIN_U2932_6_TH001_NG_101118_06_B10

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_B10

value: PICROPODOPHYLLIN


title: VINBLASTINE.SULFATE_U2932_6_TH001_NG_101118_06_B08

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_B08


title: TRIFLUPROMAZINE.HYDROCHLORIDE_U2932_6_TH001_NG_101118_06_B07

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_B07


title: SULFASALAZINE_U2932_6_TH001_NG_101118_06_B06

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_B06

value: SULFASALAZINE


title: THIOGUANINE_U2932_6_TH001_NG_101118_06_B05

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_B05

value: THIOGUANINE

value: 6 hrs


title: ERGOCALCIFEROL_U2932_6_TH001_NG_101118_06_B03

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_B03

value: ERGOCALCIFEROL


title: Primary tumor breast - BCPT0775

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status

value: discovery


title: Primary tumor breast - BCPT0348


title: ROSIGLITAZONE_U2932_6_TH001_NG_101118_06_B02

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_B02

value: ROSIGLITAZONE


title: Primary tumor breast - BCPT0906


title: Primary tumor breast - BCPT0180


title: MICONAZOLE.NITRATE_U2932_6_TH001_NG_101118_06_B04

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_B04


title: Primary tumor breast - BCPT0805


title: FENOFIBRATE_U2932_6_TH001_NG_101118_06_B01

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_B01

value: FENOFIBRATE


title: Primary tumor breast - BCPT0683


title: Primary tumor breast - BCPT0147


title: Primary tumor breast - BCPT0368


title: Primary tumor breast - BCPT0636


title: TUBOCURARINE.CHLORIDE_U2932_6_TH001_NG_101118_06_A10

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_A10


title: CHLOROXINE_U2932_6_TH001_NG_101118_06_A07

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_A07

value: CHLOROXINE


title: PINDOLOL_U2932_6_TH001_NG_101118_06_A06

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_A06

value: PINDOLOL


title: Primary tumor breast - BCPT0277


title: Metixene.hydrochloride_U2932_6_TH001_NG_101118_06_A11

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_A11


title: NISOLDIPINE_U2932_6_TH001_NG_101118_06_A09

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_A09

value: NISOLDIPINE


title: SULFINPYRAZONE_U2932_6_TH001_NG_101118_06_A05

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_A05

value: SULFINPYRAZONE


title: DMSO_U2932_6_TH001_NG_101118_06_A12

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_A12

value: DMSO


title: MITOXANTHRONE.HYDROCHLORIDE_U2932_6_TH001_NG_101118_06_A08

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_A08


title: SULCONAZOLE.NITRATE_U2932_6_TH001_NG_101118_06_A02

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_A02


title: Primary tumor breast - BCPT0301


title: HEXACHLOROPHENE_U2932_6_TH001_NG_101118_06_A04

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_A04

value: HEXACHLOROPHENE


title: Primary tumor breast - BCPT0874

value: validation


title: Primary tumor breast - BCPT0811

value: Primary tumor breast


title: CLOMIPHENE.CITRATE_U2932_6_TH001_NG_101118_06_A03

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_A03


title: REF_HeLa_NA_TH001_NG_101118_06_A01

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_A01

value: REF

value: HeLa


title: Primary tumor breast - BCPT0539


title: Primary tumor breast - BCPT0869


title: Primary tumor breast - BCPT0246


title: Primary tumor breast - BCPT0831


title: DMSO_OCI-Ly7_24_TH001_NG_101118_05_H12

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_H12

value: 24 hrs


title: FELODIPINE_OCI-Ly7_24_TH001_NG_101118_05_H10

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_H10

value: FELODIPINE


title: Primary tumor breast - BCPT0898

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status


title: Primary tumor breast - BCPT0403


title: TINIDAZOLE_OCI-Ly7_24_TH001_NG_101118_05_H06

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_H06

value: TINIDAZOLE


title: ALPROSTADIL_OCI-Ly7_24_TH001_NG_101118_05_H11

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_H11

value: ALPROSTADIL


title: Primary tumor breast - BCPT0126

value: discovery


title: Primary tumor breast - BCPT0227


title: Primary tumor breast - BCPT0929


title: RIBAVIRIN_OCI-Ly7_24_TH001_NG_101118_05_H08

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_H08

value: RIBAVIRIN


title: PENTOXIFYLLINE_OCI-Ly7_24_TH001_NG_101118_05_H09

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_H09

value: PENTOXIFYLLINE


title: Primary tumor breast - BCPT0824


title: Primary tumor breast - BCPT0924


title: Primary tumor breast - BCPT0149


title: Gemcitabine_OCI-Ly7_24_TH001_NG_101118_05_H07

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_H07

value: Gemcitabine


title: DAPSONE_OCI-Ly7_24_TH001_NG_101118_05_H02

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_H02

value: DAPSONE


title: Primary tumor breast - BCPT0762


title: PROMAZINE.HYDROCHLORIDE_OCI-Ly7_24_TH001_NG_101118_05_H05

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_H05


title: VALPROIC.ACID_OCI-Ly7_24_TH001_NG_101118_05_G12

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_G12


title: Primary tumor breast - BCPT0361


title: Primary tumor breast - BCPT0548


title: GEMFIBROZIL_OCI-Ly7_24_TH001_NG_101118_05_H03

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_H03

value: GEMFIBROZIL


title: INDAPAMIDE_OCI-Ly7_24_TH001_NG_101118_05_H04

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_H04

value: INDAPAMIDE


title: DMSO_OCI-Ly7_24_TH001_NG_101118_05_H01

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_H01

value: DMSO


title: Toremifene_OCI-Ly7_24_TH001_NG_101118_05_G11

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_G11

value: Toremifene


title: Primary tumor breast - BCPT0961

value: validation


title: Primary tumor breast - BCPT0917

value: Primary tumor breast


title: Primary tumor breast - BCPT0192


title: Primary tumor breast - BCPT0646


title: Primary tumor breast - BCPT0443


title: Primary tumor breast - BCPT0229


title: Butoconazole.nitrate_OCI-Ly7_24_TH001_NG_101118_05_G10

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_G10


title: DIMERCAPROL_OCI-Ly7_24_TH001_NG_101118_05_G09

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_G09

value: DIMERCAPROL


title: GRAMICIDIN_OCI-Ly7_24_TH001_NG_101118_05_G07

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_G07

value: GRAMICIDIN


title: CYTARABINE_OCI-Ly7_24_TH001_NG_101118_05_G08

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_G08

value: CYTARABINE

value: 24 hrs


title: TAMOXIFEN.CITRATE_OCI-Ly7_24_TH001_NG_101118_05_G05

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_G05


title: INDOMETHACIN_OCI-Ly7_24_TH001_NG_101118_05_G03

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_G03

value: INDOMETHACIN


title: ALTRETAMINE_OCI-Ly7_24_TH001_NG_101118_05_G06

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_G06

value: ALTRETAMINE


title: Primary tumor breast - BCPT0145

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status


title: HYDROCHLOROTHIAZIDE_OCI-Ly7_24_TH001_NG_101118_05_G04

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_G04

value: HYDROCHLOROTHIAZIDE


title: Primary tumor breast - BCPT0770


title: Auranofin_OCI-Ly7_24_TH001_NG_101118_05_F08

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_F08

value: Auranofin


title: BRINZOLAMIDE_U2932_6_TH001_NG_101118_06_D10

description:
tumor cell line
Therasis_Plate13_TH001_NG_20101118_06_D10

value: BRINZOLAMIDE

value: 6 hrs


title: NIZATIDINE_OCI-Ly7_24_TH001_NG_101118_05_F11

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_F11

value: NIZATIDINE


title: AMIODARONE.HYDROCHLORIDE_OCI-Ly7_24_TH001_NG_101118_05_F09

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_F09


title: Primary tumor breast - BCPT0737


title: Primary tumor breast - BCPT0613


title: Primary tumor breast - BCPT0941

value: discovery


title: TRANEXAMIC.ACID_OCI-Ly7_24_TH001_NG_101118_05_G01

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_G01


title: Primary tumor breast - BCPT0719


title: CLEMASTINE_OCI-Ly7_24_TH001_NG_101118_05_G02

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_G02

value: CLEMASTINE


title: Primary tumor breast - BCPT0757


title: Primary tumor breast - BCPT0364


title: Cladribine_OCI-Ly7_24_TH001_NG_101118_05_F12

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_F12

value: Cladribine


title: Primary tumor breast - BCPT0159


title: ENOXACIN_OCI-Ly7_24_TH001_NG_101118_05_F06

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_F06

value: ENOXACIN


title: PYRITHIONE.ZINC_OCI-Ly7_24_TH001_NG_101118_05_F07

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_F07


title: SULFAMERAZINE_OCI-Ly7_24_TH001_NG_101118_05_F05

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_F05

value: SULFAMERAZINE


title: ETHOPROPAZINE.HYDROCHLORIDE_OCI-Ly7_24_TH001_NG_101118_05_F04

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_F04


title: Primary tumor breast - BCPT0201

value: Primary tumor breast


title: CEFIXIME_OCI-Ly7_24_TH001_NG_101118_05_F10

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_F10

value: CEFIXIME


title: Primary tumor breast - BCPT0680

value: validation


title: Primary tumor breast - BCPT0967


title: GALLAMINE.TRIETHIODIDE_OCI-Ly7_24_TH001_NG_101118_05_F03

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_F03


title: Primary tumor breast - BCPT0949


title: APOMORPHINE.HYDROCHLORIDE_OCI-Ly7_24_TH001_NG_101118_05_F02

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_F02


title: Primary tumor breast - BCPT0748


title: Primary tumor breast - BCPT0544


title: Primary tumor breast - BCPT0876


title: Irinotecan.Hydrochloride_OCI-Ly7_24_TH001_NG_101118_05_E11

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_E11


title: Primary tumor breast - BCPT0877

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status


title: GLIPIZIDE_OCI-Ly7_24_TH001_NG_101118_05_E09

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_E09

value: GLIPIZIDE


title: ETOPOSIDE_OCI-Ly7_24_TH001_NG_101118_05_E06

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_E06

value: ETOPOSIDE

value: 24 hrs


title: Primary tumor breast - BCPT0432


title: Primary tumor breast - BCPT0503


title: Primary tumor breast - BCPT0996


title: Primary tumor breast - BCPT0255


title: DYCLONINE.HYDROCHLORIDE_OCI-Ly7_24_TH001_NG_101118_05_E03

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_E03


title: ECONAZOLE.NITRATE_OCI-Ly7_24_TH001_NG_101118_05_E01

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_E01


title: NITROFURAZONE_OCI-Ly7_24_TH001_NG_101118_05_E04

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_E04

value: NITROFURAZONE


title: Docetaxel_OCI-Ly7_24_TH001_NG_101118_05_E07

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_E07

value: Docetaxel


title: FOLIC.ACID_OCI-Ly7_24_TH001_NG_101118_05_F01

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_F01


title: Primary tumor breast - BCPT0056


title: CHLORMEZANONE_OCI-Ly7_24_TH001_NG_101118_05_E10

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_E10

value: CHLORMEZANONE


title: Primary tumor breast - BCPT0236


title: THIOTHIXENE_OCI-Ly7_24_TH001_NG_101118_05_E05

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_E05

value: THIOTHIXENE


title: VORINOSTAT_OCI-Ly7_24_TH001_NG_101118_05_D12

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_D12

value: VORINOSTAT


title: MITOMYCIN.C_OCI-Ly7_24_TH001_NG_101118_05_E02

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_E02


title: Primary tumor breast - BCPT0049


title: Itraconazole_OCI-Ly7_24_TH001_NG_101118_05_D11

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_D11

value: Itraconazole


title: Primary tumor breast - BCPT0256

value: discovery


title: Primary tumor breast - BCPT0721


title: BRINZOLAMIDE_OCI-Ly7_24_TH001_NG_101118_05_D10

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_D10

value: BRINZOLAMIDE


title: TRIMETHADIONE_OCI-Ly7_24_TH001_NG_101118_05_D09

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_D09

value: TRIMETHADIONE


title: Primary tumor breast - BCPT0815


title: Primary tumor breast - BCPT0284


title: TOPOTECAN.HYDROCHLORIDE_OCI-Ly7_24_TH001_NG_101118_05_D08

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_D08


title: TENIPOSIDE_OCI-Ly7_24_TH001_NG_101118_05_E08

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_E08

value: TENIPOSIDE


title: CLOZAPINE_OCI-Ly7_24_TH001_NG_101118_05_D06

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_D06

value: CLOZAPINE


title: Primary tumor breast - BCPT0283

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status

value: Primary tumor breast


title: SULINDAC_OCI-Ly7_24_TH001_NG_101118_05_D05

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_D05

value: SULINDAC


title: DEFEROXAMINE.MESYLATE_OCI-Ly7_24_TH001_NG_101118_05_D03

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_D03


title: Primary tumor breast - BCPT0934


title: MELPHALAN_OCI-Ly7_24_TH001_NG_101118_05_D01

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_D01

value: MELPHALAN


title: Primary tumor breast - BCPT0031

value: validation


title: Primary tumor breast - BCPT0802


title: ISOPROPAMIDE.IODIDE_OCI-Ly7_24_TH001_NG_101118_05_D04

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_D04


title: Primary tumor breast - BCPT0323


title: AZATHIOPRINE_OCI-Ly7_24_TH001_NG_101118_05_D02

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_D02

value: AZATHIOPRINE


title: Primary tumor breast - BCPT0182


title: TROGLITAZONE_OCI-Ly7_24_TH001_NG_101118_05_C11

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_C11

value: TROGLITAZONE

value: 24 hrs


title: Primary tumor breast - BCPT0538


title: Primary tumor breast - BCPT0691


title: DACTINOMYCIN_OCI-Ly7_24_TH001_NG_101118_05_C07

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_C07

value: DACTINOMYCIN


title: RIFABUTIN_OCI-Ly7_24_TH001_NG_101118_05_C12

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_C12

value: RIFABUTIN


title: SULFACETAMIDE_OCI-Ly7_24_TH001_NG_101118_05_C05

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_C05

value: SULFACETAMIDE


title: FULVESTRANT_OCI-Ly7_24_TH001_NG_101118_05_C10

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_C10

value: FULVESTRANT


title: DIGITOXIN_OCI-Ly7_24_TH001_NG_101118_05_C08

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_C08

value: DIGITOXIN


title: ACETOHEXAMIDE_OCI-Ly7_24_TH001_NG_101118_05_C09

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_C09

value: ACETOHEXAMIDE


title: Primary tumor breast - BCPT0045

value: discovery


title: TRIFLUOPERAZINE.HYDROCHLORIDE_OCI-Ly7_24_TH001_NG_101118_05_C06

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_C06


title: Primary tumor breast - BCPT0259


title: Primary tumor breast - BCPT0915


title: Primary tumor breast - BCPT0807


title: VINCRISTINE.SULFATE_OCI-Ly7_24_TH001_NG_101118_05_D07

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_D07


title: FLURBIPROFEN_OCI-Ly7_24_TH001_NG_101118_05_C04

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_C04

value: FLURBIPROFEN


title: Primary tumor breast - BCPT0461


title: Primary tumor breast - BCPT0316


title: ACRISORCIN_OCI-Ly7_24_TH001_NG_101118_05_C02

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_C02

value: ACRISORCIN


title: ESTRADIOL_OCI-Ly7_24_TH001_NG_101118_05_C03

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_C03

value: ESTRADIOL


title: Primary tumor breast - BCPT0857

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status

value: Primary tumor breast


title: Primary tumor breast - BCPT0325


title: Primary tumor breast - BCPT0722


title: Primary tumor breast - BCPT0063


title: IMATINIB_OCI-Ly7_24_TH001_NG_101118_05_E12

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_E12

value: IMATINIB


title: Primary tumor breast - BCPT0418


title: RISPERIDONE_OCI-Ly7_24_TH001_NG_101118_05_B12

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_B12

value: RISPERIDONE


title: Primary tumor breast - BCPT0077


title: Primary tumor breast - BCPT0735


title: Primary tumor breast - BCPT0205


title: PICROPODOPHYLLIN_OCI-Ly7_24_TH001_NG_101118_05_B10

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_B10

value: PICROPODOPHYLLIN


title: Primary tumor breast - BCPT0183

value: validation


title: Primary tumor breast - BCPT0615


title: SULFASALAZINE_OCI-Ly7_24_TH001_NG_101118_05_B06

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_B06

value: SULFASALAZINE


title: MICONAZOLE.NITRATE_OCI-Ly7_24_TH001_NG_101118_05_B04

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_B04

value: 24 hrs


title: ROSIGLITAZONE_OCI-Ly7_24_TH001_NG_101118_05_B02

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_B02

value: ROSIGLITAZONE


title: Primary tumor breast - BCPT0835


title: Primary tumor breast - BCPT0516


title: Primary tumor breast - BCPT0235


title: VINBLASTINE.SULFATE_OCI-Ly7_24_TH001_NG_101118_05_B08

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_B08


title: Mometasone.furoate_OCI-Ly7_24_TH001_NG_101118_05_B11

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_B11


title: TRIFLUPROMAZINE.HYDROCHLORIDE_OCI-Ly7_24_TH001_NG_101118_05_B07

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_B07


title: TIOCONAZOLE_OCI-Ly7_24_TH001_NG_101118_05_B09

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_B09

value: TIOCONAZOLE


title: Primary tumor breast - BCPT0011


title: THIOGUANINE_OCI-Ly7_24_TH001_NG_101118_05_B05

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_B05

value: THIOGUANINE


title: DMSO_OCI-Ly7_24_TH001_NG_101118_05_A12

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_A12

value: DMSO


title: Primary tumor breast - BCPT0076


title: MEBENDAZOLE_OCI-Ly7_24_TH001_NG_101118_05_C01

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_C01

value: MEBENDAZOLE


title: Primary tumor breast - BCPT0828


title: FENOFIBRATE_OCI-Ly7_24_TH001_NG_101118_05_B01

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_B01

value: FENOFIBRATE


title: ERGOCALCIFEROL_OCI-Ly7_24_TH001_NG_101118_05_B03

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_B03

value: ERGOCALCIFEROL


title: Primary tumor breast - BCPT0298

value: discovery


title: NISOLDIPINE_OCI-Ly7_24_TH001_NG_101118_05_A09

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_A09

value: NISOLDIPINE


title: Metixene.hydrochloride_OCI-Ly7_24_TH001_NG_101118_05_A11

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_A11


title: TUBOCURARINE.CHLORIDE_OCI-Ly7_24_TH001_NG_101118_05_A10

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_A10


title: Primary tumor breast - BCPT0194

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status


title: MITOXANTHRONE.HYDROCHLORIDE_OCI-Ly7_24_TH001_NG_101118_05_A08

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_A08


title: PINDOLOL_OCI-Ly7_24_TH001_NG_101118_05_A06

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_A06

value: PINDOLOL


title: HEXACHLOROPHENE_OCI-Ly7_24_TH001_NG_101118_05_A04

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_A04

value: HEXACHLOROPHENE


title: Primary tumor breast - BCPT0390

value: Primary tumor breast


title: SULCONAZOLE.NITRATE_OCI-Ly7_24_TH001_NG_101118_05_A02

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_A02


title: Primary tumor breast - BCPT0791


title: CHLOROXINE_OCI-Ly7_24_TH001_NG_101118_05_A07

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_A07

value: CHLOROXINE


title: Primary tumor breast - BCPT0752


title: SULFINPYRAZONE_OCI-Ly7_24_TH001_NG_101118_05_A05

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_A05

value: SULFINPYRAZONE


title: Primary tumor breast - BCPT0463


title: CLOMIPHENE.CITRATE_OCI-Ly7_24_TH001_NG_101118_05_A03

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_A03


title: Primary tumor breast - BCPT0730

value: validation


title: REF_HeLa_NA_TH001_NG_101118_05_A01

description:
tumor cell line
Therasis_Plate12_TH001_NG_20101118_05_A01

value: REF

value: HeLa


title: DMSO_OCI-Ly7_12_TH001_NG_101118_04_H12

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_H12

value: 12 hrs


title: ALPROSTADIL_OCI-Ly7_12_TH001_NG_101118_04_H11

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_H11

value: ALPROSTADIL


title: FELODIPINE_OCI-Ly7_12_TH001_NG_101118_04_H10

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_H10

value: FELODIPINE


title: Primary tumor breast - BCPT0790


title: Primary tumor breast - BCPT0389


title: RIBAVIRIN_OCI-Ly7_12_TH001_NG_101118_04_H08

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_H08

value: RIBAVIRIN


title: Primary tumor breast - BCPT0956


title: Primary tumor breast - BCPT0221


title: Primary tumor breast - BCPT0405


title: PENTOXIFYLLINE_OCI-Ly7_12_TH001_NG_101118_04_H09

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_H09

value: PENTOXIFYLLINE


title: Primary tumor breast - BCPT0666


title: PROMAZINE.HYDROCHLORIDE_OCI-Ly7_12_TH001_NG_101118_04_H05

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_H05


title: Gemcitabine_OCI-Ly7_12_TH001_NG_101118_04_H07

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_H07

value: Gemcitabine


title: Primary tumor breast - BCPT0600


title: Primary tumor breast - BCPT0933


title: Primary tumor breast - BCPT0144


title: GEMFIBROZIL_OCI-Ly7_12_TH001_NG_101118_04_H03

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_H03

value: GEMFIBROZIL


title: INDAPAMIDE_OCI-Ly7_12_TH001_NG_101118_04_H04

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_H04

value: INDAPAMIDE


title: Primary tumor breast - BCPT0938

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status


title: Primary tumor breast - BCPT0948


title: Primary tumor breast - BCPT0371


title: VALPROIC.ACID_OCI-Ly7_12_TH001_NG_101118_04_G12

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_G12


title: TINIDAZOLE_OCI-Ly7_12_TH001_NG_101118_04_H06

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_H06

value: TINIDAZOLE


title: Primary tumor breast - BCPT0332

value: discovery


title: DAPSONE_OCI-Ly7_12_TH001_NG_101118_04_H02

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_H02

value: DAPSONE


title: Primary tumor breast - BCPT0175

value: Primary tumor breast


title: CYTARABINE_OCI-Ly7_12_TH001_NG_101118_04_G08

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_G08

value: CYTARABINE


title: Butoconazole.nitrate_OCI-Ly7_12_TH001_NG_101118_04_G10

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_G10


title: Primary tumor breast - BCPT0326


title: HYDROCHLOROTHIAZIDE_OCI-Ly7_12_TH001_NG_101118_04_G04

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_G04

value: HYDROCHLOROTHIAZIDE


title: Primary tumor breast - BCPT0743

value: validation


title: DMSO_OCI-Ly7_12_TH001_NG_101118_04_H01

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_H01

value: DMSO


title: Toremifene_OCI-Ly7_12_TH001_NG_101118_04_G11

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_G11

value: Toremifene


title: CLEMASTINE_OCI-Ly7_12_TH001_NG_101118_04_G02

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_G02

value: CLEMASTINE

value: 12 hrs


title: INDOMETHACIN_OCI-Ly7_12_TH001_NG_101118_04_G03

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_G03

value: INDOMETHACIN


title: Primary tumor breast - BCPT0747


title: Primary tumor breast - BCPT0903


title: GRAMICIDIN_OCI-Ly7_12_TH001_NG_101118_04_G07

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_G07

value: GRAMICIDIN


title: ALTRETAMINE_OCI-Ly7_12_TH001_NG_101118_04_G06

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_G06

value: ALTRETAMINE


title: TAMOXIFEN.CITRATE_OCI-Ly7_12_TH001_NG_101118_04_G05

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_G05


title: DIMERCAPROL_OCI-Ly7_12_TH001_NG_101118_04_G09

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_G09

value: DIMERCAPROL


title: Primary tumor breast - BCPT0178


title: Primary tumor breast - BCPT0975


title: Primary tumor breast - BCPT0342


title: Primary tumor breast - BCPT0629


title: Primary tumor breast - BCPT0907


title: TRANEXAMIC.ACID_OCI-Ly7_12_TH001_NG_101118_04_G01

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_G01


title: NIZATIDINE_OCI-Ly7_12_TH001_NG_101118_04_F11

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_F11

value: NIZATIDINE


title: Primary tumor breast - BCPT0726

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status


title: CEFIXIME_OCI-Ly7_12_TH001_NG_101118_04_F10

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_F10

value: CEFIXIME


title: Primary tumor breast - BCPT0925


title: Cladribine_OCI-Ly7_12_TH001_NG_101118_04_F12

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_F12

value: Cladribine


title: Primary tumor breast - BCPT0580


title: AMIODARONE.HYDROCHLORIDE_OCI-Ly7_12_TH001_NG_101118_04_F09

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_F09


title: Primary tumor breast - BCPT0746


title: Primary tumor breast - BCPT0657

value: discovery


title: Primary tumor breast - BCPT0094


title: Auranofin_OCI-Ly7_12_TH001_NG_101118_04_F08

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_F08

value: Auranofin


title: ENOXACIN_OCI-Ly7_12_TH001_NG_101118_04_F06

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_F06

value: ENOXACIN


title: Primary tumor breast - BCPT0713

value: Primary tumor breast


title: Primary tumor breast - BCPT0134


title: GALLAMINE.TRIETHIODIDE_OCI-Ly7_12_TH001_NG_101118_04_F03

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_F03


title: APOMORPHINE.HYDROCHLORIDE_OCI-Ly7_12_TH001_NG_101118_04_F02

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_F02


title: FOLIC.ACID_OCI-Ly7_12_TH001_NG_101118_04_F01

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_F01


title: Irinotecan.Hydrochloride_OCI-Ly7_12_TH001_NG_101118_04_E11

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_E11


title: PYRITHIONE.ZINC_OCI-Ly7_12_TH001_NG_101118_04_F07

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_F07


title: ETHOPROPAZINE.HYDROCHLORIDE_OCI-Ly7_12_TH001_NG_101118_04_F04

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_F04


title: Primary tumor breast - BCPT0891


title: GLIPIZIDE_OCI-Ly7_12_TH001_NG_101118_04_E09

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_E09

value: GLIPIZIDE


title: Primary tumor breast - BCPT0172

value: validation


title: Primary tumor breast - BCPT0901


title: Primary tumor breast - BCPT0792


title: Primary tumor breast - BCPT0109


title: SULFAMERAZINE_OCI-Ly7_12_TH001_NG_101118_04_F05

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_F05

value: SULFAMERAZINE


title: IMATINIB_OCI-Ly7_12_TH001_NG_101118_04_E12

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_E12

value: IMATINIB


title: CHLORMEZANONE_OCI-Ly7_12_TH001_NG_101118_04_E10

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_E10

value: CHLORMEZANONE


title: Primary tumor breast - BCPT0745


title: Docetaxel_OCI-Ly7_12_TH001_NG_101118_04_E07

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_E07

value: Docetaxel

value: 12 hrs


title: TENIPOSIDE_OCI-Ly7_12_TH001_NG_101118_04_E08

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_E08

value: TENIPOSIDE


title: THIOTHIXENE_OCI-Ly7_12_TH001_NG_101118_04_E05

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_E05

value: THIOTHIXENE


title: Primary tumor breast - BCPT0008

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status


title: Primary tumor breast - BCPT0927


title: Primary tumor breast - BCPT0478


title: Primary tumor breast - BCPT0111


title: DYCLONINE.HYDROCHLORIDE_OCI-Ly7_12_TH001_NG_101118_04_E03

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_E03


title: NITROFURAZONE_OCI-Ly7_12_TH001_NG_101118_04_E04

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_E04

value: NITROFURAZONE


title: ECONAZOLE.NITRATE_OCI-Ly7_12_TH001_NG_101118_04_E01

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_E01


title: ETOPOSIDE_OCI-Ly7_12_TH001_NG_101118_04_E06

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_E06

value: ETOPOSIDE


title: Primary tumor breast - BCPT0577


title: Primary tumor breast - BCPT0861


title: Primary tumor breast - BCPT0468


title: Primary tumor breast - BCPT0640


title: Primary tumor breast - BCPT0278


title: TOPOTECAN.HYDROCHLORIDE_OCI-Ly7_12_TH001_NG_101118_04_D08

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_D08


title: Primary tumor breast - BCPT0099


title: Primary tumor breast - BCPT0522


title: Itraconazole_OCI-Ly7_12_TH001_NG_101118_04_D11

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_D11

value: Itraconazole


title: TRIMETHADIONE_OCI-Ly7_12_TH001_NG_101118_04_D09

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_D09

value: TRIMETHADIONE


title: VORINOSTAT_OCI-Ly7_12_TH001_NG_101118_04_D12

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_D12

value: VORINOSTAT


title: Primary tumor breast - BCPT0809

value: discovery


title: MITOMYCIN.C_OCI-Ly7_12_TH001_NG_101118_04_E02

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_E02


title: Primary tumor breast - BCPT0458


title: Primary tumor breast - BCPT0705


title: Primary tumor breast - BCPT0642


title: BRINZOLAMIDE_OCI-Ly7_12_TH001_NG_101118_04_D10

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_D10

value: BRINZOLAMIDE


title: VINCRISTINE.SULFATE_OCI-Ly7_12_TH001_NG_101118_04_D07

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_D07


title: Primary tumor breast - BCPT0374

value: Primary tumor breast


title: Primary tumor breast - BCPT0282


title: SULINDAC_OCI-Ly7_12_TH001_NG_101118_04_D05

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_D05

value: SULINDAC


title: Primary tumor breast - BCPT0871


title: Primary tumor breast - BCPT0264


title: Primary tumor breast - BCPT0281

value: validation


title: Primary tumor breast - BCPT0897


title: Primary tumor breast - BCPT0420


title: CLOZAPINE_OCI-Ly7_12_TH001_NG_101118_04_D06

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_D06

value: CLOZAPINE


title: Primary tumor breast - BCPT0560


title: Primary tumor breast - BCPT0050


title: ISOPROPAMIDE.IODIDE_OCI-Ly7_12_TH001_NG_101118_04_D04

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_D04


title: DEFEROXAMINE.MESYLATE_OCI-Ly7_12_TH001_NG_101118_04_D03

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_D03


title: AZATHIOPRINE_OCI-Ly7_12_TH001_NG_101118_04_D02

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_D02

value: AZATHIOPRINE


title: MELPHALAN_OCI-Ly7_12_TH001_NG_101118_04_D01

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_D01

value: MELPHALAN


title: DIGITOXIN_OCI-Ly7_12_TH001_NG_101118_04_C08

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_C08

value: DIGITOXIN


title: TRIFLUOPERAZINE.HYDROCHLORIDE_OCI-Ly7_12_TH001_NG_101118_04_C06

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_C06

value: 12 hrs


title: TROGLITAZONE_OCI-Ly7_12_TH001_NG_101118_04_C11

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_C11

value: TROGLITAZONE


title: RIFABUTIN_OCI-Ly7_12_TH001_NG_101118_04_C12

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_C12

value: RIFABUTIN


title: ESTRADIOL_OCI-Ly7_12_TH001_NG_101118_04_C03

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_C03

value: ESTRADIOL


title: ACRISORCIN_OCI-Ly7_12_TH001_NG_101118_04_C02

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_C02

value: ACRISORCIN


title: ACETOHEXAMIDE_OCI-Ly7_12_TH001_NG_101118_04_C09

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_C09

value: ACETOHEXAMIDE


title: SULFACETAMIDE_OCI-Ly7_12_TH001_NG_101118_04_C05

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_C05

value: SULFACETAMIDE


title: FULVESTRANT_OCI-Ly7_12_TH001_NG_101118_04_C10

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_C10

value: FULVESTRANT


title: DACTINOMYCIN_OCI-Ly7_12_TH001_NG_101118_04_C07

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_C07

value: DACTINOMYCIN


title: Primary tumor breast - BCPT0601

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status

value: discovery


title: FLURBIPROFEN_OCI-Ly7_12_TH001_NG_101118_04_C04

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_C04

value: FLURBIPROFEN


title: Primary tumor breast - BCPT0269

value: Primary tumor breast


title: Primary tumor breast - BCPT0914

value: validation


title: RISPERIDONE_OCI-Ly7_12_TH001_NG_101118_04_B12

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_B12

value: RISPERIDONE


title: Primary tumor breast - BCPT0085


title: Primary tumor breast - BCPT0265


title: Primary tumor breast - BCPT0123


title: VINBLASTINE.SULFATE_OCI-Ly7_12_TH001_NG_101118_04_B08

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_B08


title: PICROPODOPHYLLIN_OCI-Ly7_12_TH001_NG_101118_04_B10

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_B10

value: PICROPODOPHYLLIN


title: Primary tumor breast - BCPT0952


title: Primary tumor breast - BCPT0047


title: Primary tumor breast - BCPT0634


title: Primary tumor breast - BCPT0290


title: Primary tumor breast - BCPT0070


title: Mometasone.furoate_OCI-Ly7_12_TH001_NG_101118_04_B11

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_B11


title: SULFASALAZINE_OCI-Ly7_12_TH001_NG_101118_04_B06

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_B06

value: SULFASALAZINE


title: MEBENDAZOLE_OCI-Ly7_12_TH001_NG_101118_04_C01

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_C01

value: MEBENDAZOLE


title: Primary tumor breast - BCPT0661


title: Primary tumor breast - BCPT0887


title: MICONAZOLE.NITRATE_OCI-Ly7_12_TH001_NG_101118_04_B04

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_B04

value: 12 hrs


title: Primary tumor breast - BCPT0270


title: Primary tumor breast - BCPT0987


title: TIOCONAZOLE_OCI-Ly7_12_TH001_NG_101118_04_B09

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_B09

value: TIOCONAZOLE


title: ROSIGLITAZONE_OCI-Ly7_12_TH001_NG_101118_04_B02

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_B02

value: ROSIGLITAZONE


title: ERGOCALCIFEROL_OCI-Ly7_12_TH001_NG_101118_04_B03

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_B03

value: ERGOCALCIFEROL


title: TRIFLUPROMAZINE.HYDROCHLORIDE_OCI-Ly7_12_TH001_NG_101118_04_B07

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_B07


title: THIOGUANINE_OCI-Ly7_12_TH001_NG_101118_04_B05

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_B05

value: THIOGUANINE


title: Primary tumor breast - BCPT0715


title: FENOFIBRATE_OCI-Ly7_12_TH001_NG_101118_04_B01

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_B01

value: FENOFIBRATE


title: Primary tumor breast - BCPT0689


title: NISOLDIPINE_OCI-Ly7_12_TH001_NG_101118_04_A09

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_A09

value: NISOLDIPINE


title: TUBOCURARINE.CHLORIDE_OCI-Ly7_12_TH001_NG_101118_04_A10

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_A10


title: Primary tumor breast - BCPT0621

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status


title: Primary tumor breast - BCPT0069


title: Primary tumor breast - BCPT0133


title: CHLOROXINE_OCI-Ly7_12_TH001_NG_101118_04_A07

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_A07

value: CHLOROXINE


title: Primary tumor breast - BCPT0717


title: DMSO_OCI-Ly7_12_TH001_NG_101118_04_A12

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_A12

value: DMSO


title: Primary tumor breast - BCPT0787


title: HEXACHLOROPHENE_OCI-Ly7_12_TH001_NG_101118_04_A04

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_A04

value: HEXACHLOROPHENE


title: Primary tumor breast - BCPT0506


title: Primary tumor breast - BCPT0424


title: Primary tumor breast - BCPT0073


title: PINDOLOL_OCI-Ly7_12_TH001_NG_101118_04_A06

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_A06

value: PINDOLOL


title: Primary tumor breast - BCPT0341

value: Primary tumor breast


title: MITOXANTHRONE.HYDROCHLORIDE_OCI-Ly7_12_TH001_NG_101118_04_A08

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_A08


title: Primary tumor breast - BCPT0484

value: validation


title: Primary tumor breast - BCPT0665


title: Primary tumor breast - BCPT0653


title: CLOMIPHENE.CITRATE_OCI-Ly7_12_TH001_NG_101118_04_A03

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_A03


title: DMSO_OCI-Ly7_6_TH001_NG_101118_03_H12

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_H12

value: 6 hrs


title: Primary tumor breast - BCPT0009


title: SULCONAZOLE.NITRATE_OCI-Ly7_12_TH001_NG_101118_04_A02

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_A02


title: REF_HeLa_NA_TH001_NG_101118_04_A01

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_A01

value: REF

value: HeLa


title: ALPROSTADIL_OCI-Ly7_6_TH001_NG_101118_03_H11

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_H11

value: ALPROSTADIL


title: Metixene.hydrochloride_OCI-Ly7_12_TH001_NG_101118_04_A11

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_A11

value: 12 hrs


title: Primary tumor breast - BCPT0709

value: discovery


title: Primary tumor breast - BCPT0060


title: PENTOXIFYLLINE_OCI-Ly7_6_TH001_NG_101118_03_H09

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_H09

value: PENTOXIFYLLINE


title: Primary tumor breast - BCPT0091


title: Primary tumor breast - BCPT0137


title: Primary tumor breast - BCPT0190


title: Primary tumor breast - BCPT0935


title: Primary tumor breast - BCPT0944


title: Primary tumor breast - BCPT0451


title: Gemcitabine_OCI-Ly7_6_TH001_NG_101118_03_H07

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_H07

value: Gemcitabine


title: Primary tumor breast - BCPT0141


title: Primary tumor breast - BCPT0275


title: CYTARABINE_OCI-Ly7_6_TH001_NG_101118_03_G08

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_G08

value: CYTARABINE


title: Primary tumor breast - BCPT0720


title: Primary tumor breast - BCPT0507


title: TINIDAZOLE_OCI-Ly7_6_TH001_NG_101118_03_H06

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_H06

value: TINIDAZOLE


title: RIBAVIRIN_OCI-Ly7_6_TH001_NG_101118_03_H08

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_H08

value: RIBAVIRIN


title: INDAPAMIDE_OCI-Ly7_6_TH001_NG_101118_03_H04

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_H04

value: INDAPAMIDE


title: DAPSONE_OCI-Ly7_6_TH001_NG_101118_03_H02

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_H02

value: DAPSONE


title: Primary tumor breast - BCPT0154

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status


title: FELODIPINE_OCI-Ly7_6_TH001_NG_101118_03_H10

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_H10

value: FELODIPINE


title: DMSO_OCI-Ly7_6_TH001_NG_101118_03_H01

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_H01

value: DMSO


title: Toremifene_OCI-Ly7_6_TH001_NG_101118_03_G11

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_G11

value: Toremifene


title: VALPROIC.ACID_OCI-Ly7_6_TH001_NG_101118_03_G12

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_G12


title: GEMFIBROZIL_OCI-Ly7_6_TH001_NG_101118_03_H03

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_H03

value: GEMFIBROZIL


title: Butoconazole.nitrate_OCI-Ly7_6_TH001_NG_101118_03_G10

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_G10

value: 6 hrs


title: GRAMICIDIN_OCI-Ly7_6_TH001_NG_101118_03_G07

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_G07

value: GRAMICIDIN


title: PROMAZINE.HYDROCHLORIDE_OCI-Ly7_6_TH001_NG_101118_03_H05

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_H05


title: ALTRETAMINE_OCI-Ly7_6_TH001_NG_101118_03_G06

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_G06

value: ALTRETAMINE


title: HYDROCHLOROTHIAZIDE_OCI-Ly7_6_TH001_NG_101118_03_G04

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_G04

value: HYDROCHLOROTHIAZIDE


title: Primary tumor breast - BCPT0858

value: Primary tumor breast


title: CLEMASTINE_OCI-Ly7_6_TH001_NG_101118_03_G02

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_G02

value: CLEMASTINE


title: Primary tumor breast - BCPT0921

value: validation


title: CEFIXIME_OCI-Ly7_6_TH001_NG_101118_03_F10

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_F10

value: CEFIXIME


title: DIMERCAPROL_OCI-Ly7_6_TH001_NG_101118_03_G09

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_G09

value: DIMERCAPROL


title: SULFAMERAZINE_OCI-Ly7_6_TH001_NG_101118_03_F05

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_F05

value: SULFAMERAZINE


title: Primary tumor breast - BCPT0559

value: discovery


title: Primary tumor breast - BCPT0826


title: Primary tumor breast - BCPT0244


title: Primary tumor breast - BCPT0062


title: Cladribine_OCI-Ly7_6_TH001_NG_101118_03_F12

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_F12

value: Cladribine


title: Primary tumor breast - BCPT0881


title: PYRITHIONE.ZINC_OCI-Ly7_6_TH001_NG_101118_03_F07

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_F07


title: AMIODARONE.HYDROCHLORIDE_OCI-Ly7_6_TH001_NG_101118_03_F09

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_F09


title: ENOXACIN_OCI-Ly7_6_TH001_NG_101118_03_F06

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_F06

value: ENOXACIN


title: GALLAMINE.TRIETHIODIDE_OCI-Ly7_6_TH001_NG_101118_03_F03

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_F03


title: Primary tumor breast - BCPT0434

description: Some arrays correspond to multiple study subjects, which is indicated by the setnr/case-control status


title: ETHOPROPAZINE.HYDROCHLORIDE_OCI-Ly7_6_TH001_NG_101118_03_F04

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_F04


title: Primary tumor breast - BCPT0304


title: TAMOXIFEN.CITRATE_OCI-Ly7_6_TH001_NG_101118_03_G05

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_G05


title: Primary tumor breast - BCPT0589


title: NIZATIDINE_OCI-Ly7_6_TH001_NG_101118_03_F11

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_F11

value: NIZATIDINE


title: Primary tumor breast - BCPT0511


title: SULFINPYRAZONE_OCI-Ly7_12_TH001_NG_101118_04_A05

description:
tumor cell line
Therasis_Plate11_TH001_NG_20101118_04_A05

value: SULFINPYRAZONE

value: 12 hrs


title: Auranofin_OCI-Ly7_6_TH001_NG_101118_03_F08

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_F08

value: Auranofin


title: INDOMETHACIN_OCI-Ly7_6_TH001_NG_101118_03_G03

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_G03

value: INDOMETHACIN

value: 6 hrs


title: TRANEXAMIC.ACID_OCI-Ly7_6_TH001_NG_101118_03_G01

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_G01


title: APOMORPHINE.HYDROCHLORIDE_OCI-Ly7_6_TH001_NG_101118_03_F02

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_F02


title: Primary tumor breast - BCPT0695


title: Primary tumor breast - BCPT0894


title: Primary tumor breast - BCPT0441


title: FOLIC.ACID_OCI-Ly7_6_TH001_NG_101118_03_F01

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_F01


title: IMATINIB_OCI-Ly7_6_TH001_NG_101118_03_E12

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_E12

value: IMATINIB


title: UBS123 Unbound fraction Sleep animal, biological rep 1

city: Madison

first: Michele

last: Bellesi

state: WI

address: 6001 Research Park Blvd

institute: University Wisconsin-Madison

description: Expression data from the unbound fraction of sleeping mice

hyb_protocol: Samples were hybridized to Affymetrix GeneChip Mouse Genome 430 2.0 arrays (n=24) following Affymetrix standard protocol

scan_protocol: Samples were scanned using the GC3000 7G scanner (Affymetrix)

data_processing: For both IP and UB replicates, GeneChip Cel files were imported into Bioconductor, data were converted to log2 scale, and transcripts called “absent” in all chips were not used for analysis. Data were normalized within each behavioral state group using Robust Multi-array Average (RMA, (Irizarry et al., 2003)).

organism: Mus musculus

source_name: Unbound fraction Sleep animal

label_protocol: Five µg of amplified material was then fragmented, biotin labeled with the Encore Biotin Module (Nugen, #4200)

extract_protocol: RNA, which represents the mRNA immunoprecipitated from the targeted cell type (B fraction), was purified following the Nanoprep protocol including on column DNase digestion. The RNA from the supernatant (unbound fraction; UB) was isolated using the RNeasy Mini kit (Qiagen).

treatment_protocol:
sleep protocol: sleeping mice were killed during the light phase (at ~3-5 pm), at the end of a long period of sleep (> 45 min, interrupted by periods of wake of < 4 min), and after spending at least 75% of the previous 6–7 h asleep.
waking protocol: awake mice were killed during the dark period (at ~3-5 am) at the end of a long period of wake (> 1 h, interrupted by periods of sleep of < 5 min), and after spending at least 70% of the previous 6–7 h awake.
sleep deprivation protocol: sleep deprived mice were spontaneously awake during most of the dark phase and then maintained awake during the light period for 4h by exposure to novel objects.

tag: genotype/variation

value: aldh1l1 - eGFP-L10a

tag: sample type

value: unbound fraction of sleeping mice


title: UBW456 Unbound fraction Waking animal, biological rep 2

description: Expression data from the unbound fraction of waking mice

source_name: Unbound fraction Waking animal

value: unbound fraction of waking mice


title: TENIPOSIDE_OCI-Ly7_6_TH001_NG_101118_03_E08

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_E08

value: TENIPOSIDE


title: SD5 Bound fraction Sleep dep animal, biological rep 5

description: Expression data from the bound fraction of sleep deprived mice

source_name: Bound fraction Sleep deprived animal

value: bound fraction of sleep deprived mice


title: UBW123 Unbound fraction Waking animal, biological rep 1


title: SD3 Bound fraction Sleep dep animal, biological rep 3


title: UBS456 Unbound fraction Sleep animal, biological rep 2


title: W1 Bound fraction Waking animal, biological rep 1

description: Expression data from the bound fraction of waking mice

source_name: Bound fraction Waking animal

value: bound fraction of waking mice


title: W4 Bound fraction Waking animal, biological rep 4


title: GLIPIZIDE_OCI-Ly7_6_TH001_NG_101118_03_E09

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_E09

value: GLIPIZIDE


title: Irinotecan.Hydrochloride_OCI-Ly7_6_TH001_NG_101118_03_E11

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_E11


title: CHLORMEZANONE_OCI-Ly7_6_TH001_NG_101118_03_E10

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_E10

value: CHLORMEZANONE


title: W6 Bound fraction Waking animal, biological rep 6


title: SD1 Bound fraction Sleep dep animal, biological rep 1


title: SD4 Bound fraction Sleep dep animal, biological rep 4


title: Docetaxel_OCI-Ly7_6_TH001_NG_101118_03_E07

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_E07

value: Docetaxel


title: SD2 Bound fraction Sleep dep animal, biological rep 2


title: SD6 Bound fraction Sleep dep animal, biological rep 6


title: W5 Bound fraction Waking animal, biological rep 5


title: UBSD456 Unbound fraction Sleep dep animal, biological rep 2

description: Expression data from the unbound fraction of sleep deprived mice

source_name: Unbound fraction Sleep deprived animal

value: unbound fraction of sleep deprived mice


title: ETOPOSIDE_OCI-Ly7_6_TH001_NG_101118_03_E06

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_E06

value: ETOPOSIDE


title: W3 Bound fraction Waking animal, biological rep 3


title: THIOTHIXENE_OCI-Ly7_6_TH001_NG_101118_03_E05

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_E05

value: THIOTHIXENE


title: UBSD123 Unbound fraction Sleep dep animal, biological rep 1


title: W2 Bound fraction Waking animal, biological rep 2


title: NITROFURAZONE_OCI-Ly7_6_TH001_NG_101118_03_E04

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_E04

value: NITROFURAZONE


title: S6 Bound fraction Sleep animal, biological rep 6

description: Expression data from the bound fraction of sleeping mice

source_name: Bound fraction Sleep animal

value: bound fraction of sleeping mice


title: DYCLONINE.HYDROCHLORIDE_OCI-Ly7_6_TH001_NG_101118_03_E03

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_E03


title: MITOMYCIN.C_OCI-Ly7_6_TH001_NG_101118_03_E02

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_E02


title: S3 Bound fraction Sleep animal, biological rep 3


title: VORINOSTAT_OCI-Ly7_6_TH001_NG_101118_03_D12

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_D12

value: VORINOSTAT


title: shRNA control, replicate 3

city: Boston

first: Adrian

last: Dubuc

state: Massachussetts

address: 75 Francis St, 5-5066 Shapiro Building

institute: Brigham and Women's Hospital

hyb_protocol: Following fragmentation, 10 ug of cRNA were hybridized for 16 hr at 45C on GeneChip Drosophila Genome Array. GeneChips were washed and stained in the Affymetrix Fluidics Station 400.

scan_protocol: GeneChips were scanned using the Hewlett-Packard GeneArray Scanner G2500A.

data_processing: The data were analyzed with Expression Console (v.1.1) using Affymetrix default RMA-sketch gene-level analysis.

source_name: shRNA control

label_protocol: Biotinylated cRNA were prepared according to the standard Affymetrix protocol from 6 ug total RNA (Expression Analysis Technical Manual, 2001, Affymetrix).

growth_protocol: Cell culture was performed and as previously described (PMID:22855790)

extract_protocol: Trizol extraction of total RNA was performed according to the manufacturer's instructions.

treatment_protocol: Treatment prtocols were performed as previously described (PMID:22855790)

tag: cell type

value: medulloblastoma (MB) cell line

value: control shRNA-treated


title: mock-treatment, replicate 1

source_name: mock-treatment

value: DMSO-treated (mock control)


title: pharmacologically inhibited EAG2, replicate 3

source_name: pharmacologically inhibited EAG2

value: pharmacologically inhibited EAG2


title: Itraconazole_OCI-Ly7_6_TH001_NG_101118_03_D11

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_D11

value: Itraconazole

value: 6 hrs


title: S5 Bound fraction Sleep animal, biological rep 5

value: aldh1l1 - eGFP-L10a


title: CLOZAPINE_OCI-Ly7_6_TH001_NG_101118_03_D06

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_D06

value: CLOZAPINE


title: T-PLL post 3

city: Hershey

first: Penn State

last: COM

state: PA

address: 500 University Drive

department: Genome Sciences Facility

institute: Penn State College of Medicine

description:
Replicate 3
5154922028_J

hyb_protocol: Standard Illumina hybridization protocol

scan_protocol: Standard Illumina scanning protocol

data_processing: The data were normalised using quantile normalization

source_name: PBMC

label_protocol: Biotinylated cRNA were prepared with the Ambion TotalPrep kit for Illumina arrays

extract_protocol: RNA was extracted with Trizol reagent, followed by clean-up and DNase I treatment with QIAGEN RNeasy mini kit in accordance with the prescribed protocol provided with the kit.  Quality control was performed with Agilent Bioanalyser.

tag: treatment status

value: 3 days post-treatment

tag: treatment

value: alemtuzumab, cladribine

tag: additional treatment


title: TOPOTECAN.HYDROCHLORIDE_OCI-Ly7_6_TH001_NG_101118_03_D08

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_D08


title: pharmacologically inhibited EAG2, replicate 1


title: T-PLL post 4

description:
Replicate 4
5154922028_L


title: S1 Bound fraction Sleep animal, biological rep 1


title: mock-treatment, replicate 2


title: T-PLL post 2

description:
Replicate 2
5154922028_H

value: vorinostat


title: TRIMETHADIONE_OCI-Ly7_6_TH001_NG_101118_03_D09

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_D09

value: TRIMETHADIONE


title: mock-treatment, replicate 3


title: shRNA control, replicate 1


title: T-PLL post 1

description:
Replicate 1
5154922028_F


title: S2 Bound fraction Sleep animal, biological rep 2


title: VINCRISTINE.SULFATE_OCI-Ly7_6_TH001_NG_101118_03_D07

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_D07


title: BRINZOLAMIDE_OCI-Ly7_6_TH001_NG_101118_03_D10

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_D10

value: BRINZOLAMIDE


title: T-PLL pre 4

description:
Replicate 4
5154922028_K

value: pre-treatment


title: ECONAZOLE.NITRATE_OCI-Ly7_6_TH001_NG_101118_03_E01

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_E01


title: pharmacologically inhibited EAG2, replicate 2


title: S4 Bound fraction Sleep animal, biological rep 4


title: shRNA control, replicate 2


title: T-PLL pre 2

description:
Replicate 2
5154922028_G


title: shRNA-inibited EAG2, replicate 1

source_name: shRNA-inibited EAG2

value: shRNA-mediated silencing of EAG2


title: SULINDAC_OCI-Ly7_6_TH001_NG_101118_03_D05

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_D05

value: SULINDAC


title: ISOPROPAMIDE.IODIDE_OCI-Ly7_6_TH001_NG_101118_03_D04

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_D04


title: DEFEROXAMINE.MESYLATE_OCI-Ly7_6_TH001_NG_101118_03_D03

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_D03


title: shRNA-inibited EAG2, replicate 3


title: Normal CD3+/CD8+ 4

description:
Replicate 4
5154922028_D


title: AZATHIOPRINE_OCI-Ly7_6_TH001_NG_101118_03_D02

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_D02

value: AZATHIOPRINE


title: Normal CD3+/CD8+ 1

description:
Replicate 1
5154922028_A


title: RIFABUTIN_OCI-Ly7_6_TH001_NG_101118_03_C12

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_C12

value: RIFABUTIN


title: T-PLL pre 1

description:
Replicate 1
5154922028_E


title: DACTINOMYCIN_OCI-Ly7_6_TH001_NG_101118_03_C07

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_C07

value: DACTINOMYCIN


title: ACETOHEXAMIDE_OCI-Ly7_6_TH001_NG_101118_03_C09

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_C09

value: ACETOHEXAMIDE


title: shRNA-inibited EAG2, replicate 2

value: medulloblastoma (MB) cell line


title: Normal CD3+/CD8+ 2

description:
Replicate 2
5154922028_B


title: MELPHALAN_OCI-Ly7_6_TH001_NG_101118_03_D01

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_D01

value: MELPHALAN


title: TROGLITAZONE_OCI-Ly7_6_TH001_NG_101118_03_C11

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_C11

value: TROGLITAZONE

value: 6 hrs


title: Normal CD3+/CD8+ 3

description:
Replicate 3
5154922028_C


title: FULVESTRANT_OCI-Ly7_6_TH001_NG_101118_03_C10

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_C10

value: FULVESTRANT


title: SULFACETAMIDE_OCI-Ly7_6_TH001_NG_101118_03_C05

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_C05

value: SULFACETAMIDE


type: genomic

city: Beijing

first: Haibo

last: Yang

address: No.1 Beichen West Road, Chaoyang District

country: China

institute: Institute of Microbiology, Chinese Academy of Sciences

description: Haloferax mediterranei DF50ΔoriC3 genomic DNA of exponential phase vs that of stationary phase

hyb_protocol: standard CapitalBio Methods

scan_protocol: Arrays were scanned on an MS200 scanner per manufacturer's protocol

data_processing: Arrays were processed using Nimblegen's standard protocol. The ratios were calculated as exponential phase values (or at time points 12h, 18h, 24h, 36h and 42h) versus stationary phase values for each probe. As the probes were designed according to the former version genome of Haloferax mediterranei (CP001868.1-CP001871.1), the position of the probes was adjusted according to the latest version genome of Haloferax mediterranei (CP001868.2, CP001869.1-CP001871.1) when we plot the replication profile. The difference between the former version CP001868.1 and the latest version CP001868.2 is a 1 Mb fragment inversion between the two rRNA operons in the chromosome, while the nucleotide sequences are the same. Thus, we just invert the position of probes between two rRNA operons (corresponding to probes between 33500CHROMOSOMES001745415 and 33500CHROMOSOMES002842080). Due to the high density of the probes, the ratios of the thirty probes were averaged as one point located at the first probe. The MFA graph was plotted with a 5-point window and 1-point slide.

molecule: genomic DNA

organism: Haloferax mediterranei

source_name: Genomic DNA of Haloferax mediterraneiDF50ΔoriC3 at exponential phase

label_protocol: 1 µg sonicated genomic DNA  was labeled by Klenow (New England Biolabs) random priming with Cy3 or Cy5 nonamers per manufacturer's protocol

growth_protocol: Cells  were grown at 37°C until OD600 reached 0.5 in AS-168 medium supplemented with uracil

extract_protocol: Proteinase K, ethanol precipitation, RNaseA treatment, phenol-chloroform extraction as described previously [PMID: 24271389]

treatment_protocol: no treatment

tag: strain

tag: phase

value: exponential phase

source_name: Genomic DNA of Haloferax mediterraneiDF50ΔoriC3 at stationary phase

growth_protocol: Cells were cultivated at 37°C to stationary phase in AS-168 medium supplemented with uracil

value: stationary phase


title: TRIFLUOPERAZINE.HYDROCHLORIDE_OCI-Ly7_6_TH001_NG_101118_03_C06

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_C06


title: ESTRADIOL_OCI-Ly7_6_TH001_NG_101118_03_C03

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_C03

value: ESTRADIOL


title: FLURBIPROFEN_OCI-Ly7_6_TH001_NG_101118_03_C04

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_C04

value: FLURBIPROFEN


title: DIGITOXIN_OCI-Ly7_6_TH001_NG_101118_03_C08

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_C08

value: DIGITOXIN


title: ACRISORCIN_OCI-Ly7_6_TH001_NG_101118_03_C02

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_C02

value: ACRISORCIN


description: Haloferax mediterranei DF50ΔoriC1ΔoriC3 genomic DNA of exponential phase vs that of stationary phase

source_name: Genomic DNA of Haloferax mediterraneiDF50ΔoriC1ΔoriC3 at exponential phase

source_name: Genomic DNA of Haloferax mediterraneiDF50ΔoriC1ΔoriC3 at stationary phase


description: Haloferax mediterranei DF50ΔoriC2 genomic DNA of exponential phase vs that of stationary phase

source_name: Genomic DNA of Haloferax mediterraneiDF50ΔoriC2 at exponential phase

source_name: Genomic DNA of Haloferax mediterraneiDF50ΔoriC2 at stationary phase


description: Haloferax mediterranei DF50ΔoriC1 genomic DNA of exponential phase vs that of stationary phase

source_name: Genomic DNA of Haloferax mediterraneiDF50ΔoriC1 at exponential phase

source_name: Genomic DNA of Haloferax mediterraneiDF50ΔoriC1 at stationary phase


title: PICROPODOPHYLLIN_OCI-Ly7_6_TH001_NG_101118_03_B10

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_B10

value: PICROPODOPHYLLIN


title: PCg1_BaselineL

city: Atlanta

first: Gregory

middle: K

last: Tharp

state: GA

address: 954 Gatewood Dr

department: Developmental and Cognitive Neuroscience

institute: Yerkes National Primate Research Center

hyb_protocol: Arrays were washed, stained and scanned as described in the Affymetrix GeneChip® Expression Analysis Technical Manual

scan_protocol: GeneChips were scanned using the Affymetrix GeneChip Scanner 3000 7G.

data_processing: Background adjustment, normalization, and median polish summarization of .CEL files were performed with the robust multichip average (RMA) algorithm using the affy Bioconductor package.

organism: Macaca nemestrina

source_name: PCg1 Vaginal pinch biopsy luteal  phase

label_protocol: Five µg of the amplified cDNA was fragmented, biotinylated, and hybridized to arrays using the NuGEN Ovation Encore Biotin Module, according to kit instructions.

extract_protocol: Total RNA extraction was performed using the RNeasy mini kit (QIAGEN, Hilden, Germany)

tag: animal id

tag: menstrual phase

value: luteal

value: Vaginal pinch biopsy


description: Haloferax mediterranei DF50 genomic DNA of 24h vs that of stationary phase

source_name: Genomic DNA of Haloferax mediterranei at 24h

growth_protocol: Cells were cultivated at 37°C for 24h in AS-168 medium supplemented with uracil

tag: time point

source_name: Genomic DNA of Haloferax mediterranei DF50 at stationary phase


title: RISPERIDONE_OCI-Ly7_6_TH001_NG_101118_03_B12

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_B12

value: RISPERIDONE


title: VINBLASTINE.SULFATE_OCI-Ly7_6_TH001_NG_101118_03_B08

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_B08


title: SULFASALAZINE_OCI-Ly7_6_TH001_NG_101118_03_B06

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_B06

value: SULFASALAZINE


description: Haloferax mediterranei DF50 genomic DNA of 36h vs that of stationary phase

source_name: Genomic DNA of Haloferax mediterranei at 36h

growth_protocol: Cells werecultivated at 37°C for 36h in AS-168 medium supplemented with uracil


title: MEBENDAZOLE_OCI-Ly7_6_TH001_NG_101118_03_C01

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_C01

value: MEBENDAZOLE


description: Haloferax mediterranei DF50 genomic DNA of 42h vs that of stationary phase

source_name: Genomic DNA of Haloferax mediterranei at 42h

growth_protocol: Cells were cultivated at 37°C for 42h in AS-168 medium supplemented with uracil


title: ERGOCALCIFEROL_OCI-Ly7_6_TH001_NG_101118_03_B03

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_B03

value: ERGOCALCIFEROL


title: 96PO61_BaselineL

source_name: 96PO61 Vaginal pinch biopsy luteal  phase


title: Mometasone.furoate_OCI-Ly7_6_TH001_NG_101118_03_B11

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_B11


title: 96PO47_BaselineL

source_name: 96PO47 Vaginal pinch biopsy luteal  phase


title: TIOCONAZOLE_OCI-Ly7_6_TH001_NG_101118_03_B09

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_B09

value: TIOCONAZOLE


title: PKg2_BaselineL

source_name: PKg2 Vaginal pinch biopsy luteal  phase


description: Haloferax mediterranei DF50 genomic DNA of 18h vs that of stationary phase

source_name: Genomic DNA of Haloferax mediterranei at 18h

growth_protocol: Cells were cultivated at 37°C for 18h in AS-168 medium supplemented with uracil


title: 96PO61_BaselineF

source_name: 96PO61 Vaginal pinch biopsy follicular phase

value: follicular


title: MICONAZOLE.NITRATE_OCI-Ly7_6_TH001_NG_101118_03_B04

description:
tumor cell line
Therasis_Plate10_TH001_NG_20101118_03_B04

value: 6 hrs


title: PZm1_BaselineF

source_name: PZm1 Vaginal pinch biopsy follicular phase